DMEA Call for Papers: Digital Health in All its Diversity

DMEA - Connecting Digital Health26 - 28 April 2022, Berlin, Germany.
Health meets digitalisation. From 26 to 28 April 2022 DMEA - Connecting Digital Health, the leading platform for health IT, is opening its doors again on the Berlin Exhibition Grounds.

Experts representing business and science as well as practitioners are invited to shape next year's all-day event programme with their contributions. From now until 2 December they can submit their papers for this event.

Who can take part?

The call for papers is open and free for anyone involved in the digital transformation of the healthcare sector: researchers, users in the medical and nursing professions, startups and major companies.

The abstracts submitted must deal with one of the 14 topics decided upon by the DMEA advisory committee for next year's event. They are:

1. Connected Care 2022: Are we finally getting there?

2. Cloud in Healthcare: Conflict with On-site Services vs. Solution of the Resource Problem

3. Digital Maturity Assessments - Objectives, Methods, Tools, Experiences and Expectations

4. Digitalisation in Nursing Care - Not only in Hospitals

5. Use of Artificial Intelligence in Medical Care

6. Cross-sectoral Integration of Electronic Patient Records in Care Processes

7. I am not a Computer Specialist - How to build up Digital Competence

8. Information Security in Inpatient and Outpatient Care

9. Organisation of IT in the Digital Transformation

10. Semantic Interoperability

11. Future Services of the German Health Telematics Infrastructure

12. ePrescriptions and Medication: Implementation and Experience

13. European Specifications and Projects for IT in the Healthcare Sector

14. The Future of Digitally Interconnected Medical Practices

Candidates are welcome to attend open meetings on 03 and 10 November where they can find out more about how to apply, the necessary requirements, and ask any questions they may have.

After the deadline for submissions on 02 December all the entries will be assessed by a panel made up of representatives of associations, ministries, self-government, industry and science.

Information on how to apply and details of the call for papers can be found at: www.dmea.de/en/Programm/Call-for-Papers

DMEA 2022 to be an in-person event again

Due to the pandemic DMEA was twice held as an entirely virtual event, but in 2022 is scheduled as an in-person event again. The focus will be on networking and building contacts - naturally in strict compliance with the applicable hygiene measures.

About DMEA

DMEA is Europe's leading event for health IT which gathers decision-makers from every area of the healthcare sector - including IT specialists, physicians, hospital and nursing care executives as well as experts from politics, science and research. In 2019 a total of 11,000 trade visitors came to DMEA to find out about the latest developments and products, acquire qualifications and establish important industry contacts. The next DMEA will take place from 26 to 28 April 2022 in Berlin.

DMEA is held by the German Association of Healthcare IT Vendors (bvitg) and organised by Messe Berlin. It is organised in cooperation with the following industry associations: the German Association of Healthcare IT Vendors (bvitg), the German Association for Medical Informatics, Biometry and Epidemiology (GMDS), the German Medical Informatics Professional Association (BVMI). The National Association of Hospital IT Managers (KH-IT) and the Chief Information Officers of University Hospitals (CIO-UK) provide contributions on the subject matter.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...